US3169967A
(en)
|
1957-11-14 |
1965-02-16 |
Ciba Geigy Corp |
Methyl o-lower alkanoyl-reserpates
|
US3037980A
(en)
|
1955-08-18 |
1962-06-05 |
Burroughs Wellcome Co |
Pyrrolopyrimidine vasodilators and method of making them
|
DE1770420U
(de)
|
1958-02-27 |
1958-07-17 |
Tara Union G M B H |
Blumentopf aus kunststoff.
|
US3506643A
(en)
|
1966-12-09 |
1970-04-14 |
Max Thiel |
N**6-aralkyl-adenosine derivatives
|
DE2139107A1
(de)
|
1971-08-04 |
1973-02-15 |
Merck Patent Gmbh |
Heterocyclisch substituierte adenosinverbindungen
|
US3814251A
(en)
|
1972-08-09 |
1974-06-04 |
Sperry Rand Corp |
Power transmission
|
US3962443A
(en)
|
1972-08-14 |
1976-06-08 |
Dainippon Pharmaceutical Co., Ltd. |
Antibacterial pharmaceutical compositions and processes for preparation thereof
|
DE2248232A1
(de)
|
1972-10-02 |
1974-04-11 |
Basf Ag |
4-thiopyrimido eckige klammer auf 4,5-d eckige klammer zu pyrimidine
|
AR204003A1
(es)
|
1973-04-03 |
1975-11-12 |
Dainippon Pharmaceutical Co |
Procedimiento para preparar compuestos derivados del acido 2-(1-piperazinil)-5-oxopirido-(2,3-d)pirimidino-6-carboxilico y sus sales farmaceuticamente aceptables
|
US3936454A
(en)
|
1973-08-14 |
1976-02-03 |
Warner-Lambert Company |
5-Amino-4-chloro-6-(substituted amino)-pyrimidines
|
US3862189A
(en)
|
1973-08-14 |
1975-01-21 |
Warner Lambert Co |
Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents
|
DK3375A
(pl)
|
1974-01-25 |
1975-09-15 |
Ciba Geigy Ag |
|
JPS587626B2
(ja)
|
1974-02-13 |
1983-02-10 |
大日本製薬株式会社 |
ナフチリジン オヨビ キノリンユウドウタイノセイホウ
|
JPS50111080U
(pl)
|
1974-02-21 |
1975-09-10 |
|
|
JPS5625234Y2
(pl)
|
1976-01-17 |
1981-06-15 |
|
|
JPS5359663A
(en)
|
1976-11-09 |
1978-05-29 |
Sumitomo Chem Co Ltd |
2-halogeno methyl indole derivatives and process for praparation of the same
|
JPS52106897A
(en)
|
1977-01-10 |
1977-09-07 |
Dainippon Pharmaceut Co Ltd |
Synthesis of piperazine derivatives
|
JPS5392767A
(en)
|
1977-01-27 |
1978-08-15 |
Sumitomo Chem Co Ltd |
Preparation of 2-phthalimidomethylindole derivatives
|
JPS5625234A
(en)
|
1979-08-02 |
1981-03-11 |
Hitachi Denshi Ltd |
Dropout display system
|
JPS56123981U
(pl)
|
1980-02-20 |
1981-09-21 |
|
|
JPS56123981A
(en)
|
1981-02-23 |
1981-09-29 |
Dainippon Pharmaceut Co Ltd |
Preparation of 1,4-disubstituted piperazine
|
JPS5883698A
(ja)
|
1981-11-13 |
1983-05-19 |
Takeda Chem Ind Ltd |
キノン化合物およびその製造法
|
JPS5883698U
(ja)
|
1981-11-27 |
1983-06-06 |
石川島播磨重工業株式会社 |
熱交換器
|
JPS58162949A
(ja)
|
1982-03-20 |
1983-09-27 |
Konishiroku Photo Ind Co Ltd |
ハロゲン化銀カラ−写真感光材料
|
JPS60140373U
(ja)
|
1984-02-28 |
1985-09-17 |
東洋ハ−ネス株式会社 |
ワイヤハ−ネスのア−ス構造
|
JPS6190153A
(ja)
|
1984-10-09 |
1986-05-08 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料の処理方法
|
JPS62103640A
(ja)
|
1985-07-18 |
1987-05-14 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料
|
JPS62103640U
(pl)
|
1985-12-18 |
1987-07-02 |
|
|
JPH07119970B2
(ja)
|
1986-04-18 |
1995-12-20 |
富士写真フイルム株式会社 |
画像形成方法
|
JPS6310746A
(ja)
|
1986-07-01 |
1988-01-18 |
Tanabe Seiyaku Co Ltd |
ナフタレン誘導体
|
CA1324609C
(en)
|
1986-07-30 |
1993-11-23 |
Eastman Kodak Company |
Photographic element and process
|
US4861701A
(en)
|
1987-10-05 |
1989-08-29 |
Eastman Kodak Company |
Photographic element and process comprising a compound which comprises two timing groups in sequence
|
AT388372B
(de)
|
1987-10-08 |
1989-06-12 |
Tanabe Seiyaku Co |
Neue naphthalinderivate und sie enthaltende pharmazeutika
|
JPH01250316A
(ja)
|
1987-12-28 |
1989-10-05 |
Tanabe Seiyaku Co Ltd |
抗脂血剤
|
EP0364598A4
(en)
|
1988-03-02 |
1992-01-15 |
Yoshitomi Pharmaceutical Industries, Ltd. |
3,4-dihydrothieno 2,3-d¨pyrimidine compounds and pharmaceutical application thereof
|
US5208250A
(en)
|
1988-05-25 |
1993-05-04 |
Warner-Lambert Company |
Known and selected novel arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and anti-inflammatory agents
|
UA27031A1
(uk)
|
1990-04-25 |
2000-02-28 |
Ніссан Кемікал Індастріз Лтд |
Похідhі 3(2h)піридазиhоhу або їх фармацевтичhо прийhятhі солі, що мають протитромботичhу, позитивhу іhотропhу, судиhорозширювальhу дію й аhтиалергічhу активhість та фармацевтичhа композиція hа їх осhові
|
SU1712359A1
(ru)
|
1990-05-07 |
1992-02-15 |
Уфимский Нефтяной Институт |
Гидрохлорид 8 @ -гидроксихинолинового эфира 8-гидроксихинолин-7-карбоновой кислоты, в качестве бактерицида дл подавлени сульфатвосстанавливающих бактерий и культур РSеUDомоNаS и АRтнRовастеR
|
DE69129389T2
(de)
|
1990-06-28 |
1998-10-08 |
Fuji Photo Film Co Ltd |
Photographische Silberhalogenidmaterialien
|
EP0481614A1
(en)
|
1990-10-01 |
1992-04-22 |
Merck & Co. Inc. |
Substituted pyridopyrimidinones and related heterocycles as angiotensin II antagonists
|
JPH04190232A
(ja)
|
1990-11-26 |
1992-07-08 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラー写真感光材料
|
US5480883A
(en)
|
1991-05-10 |
1996-01-02 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
AU1625192A
(en)
|
1991-05-31 |
1992-12-03 |
Zeneca Limited |
Heterocyclic derivatives
|
JP3108483B2
(ja)
|
1991-09-30 |
2000-11-13 |
日清製粉株式会社 |
インドール誘導体およびこれを有効成分とする抗潰瘍薬
|
HUT64064A
(en)
|
1992-02-13 |
1993-11-29 |
Chinoin Gyogyszer Es Vegyeszet |
Process for producing puyrido/1,2-a/pyrimidine derivatives and pharmaceutical compositions comprising same as active ingredient
|
US5521184A
(en)
|
1992-04-03 |
1996-05-28 |
Ciba-Geigy Corporation |
Pyrimidine derivatives and processes for the preparation thereof
|
AU3933493A
(en)
|
1992-04-24 |
1993-11-29 |
E.I. Du Pont De Nemours And Company |
Arthropodicidal and fungicidal aminopyrimidines
|
TW229140B
(pl)
|
1992-06-05 |
1994-09-01 |
Shell Internat Res Schappej B V |
|
FR2714907B1
(fr)
|
1994-01-07 |
1996-03-29 |
Union Pharma Scient Appl |
Nouveaux dérivés de l'Adénosine, leurs procédés de préparation, compositions pharmaceutiques les contenant.
|
US6342501B1
(en)
|
1994-02-25 |
2002-01-29 |
The Regents Of The University Of Michigan |
Pyrrolo[2,3-d] pyrimidines as antiviral agents
|
JPH0987282A
(ja)
|
1995-09-21 |
1997-03-31 |
Kyowa Hakko Kogyo Co Ltd |
チアゾール誘導体
|
JPH09176162A
(ja)
|
1995-12-22 |
1997-07-08 |
Toubishi Yakuhin Kogyo Kk |
チアゾリジンジオン誘導体及びその製造法並びにそれを含む医薬組成物
|
JPH09176116A
(ja)
|
1995-12-27 |
1997-07-08 |
Toray Ind Inc |
複素環誘導体およびその医薬用途
|
JPH1025294A
(ja)
|
1996-03-26 |
1998-01-27 |
Akira Matsuda |
縮合ヘテロ環誘導体、その製造法及びそれを含有する悪性腫瘍治療剤
|
WO1997048697A1
(en)
|
1996-06-19 |
1997-12-24 |
Rhone-Poulenc Rorer Limited |
Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
|
ES2232871T3
(es)
|
1996-07-03 |
2005-06-01 |
Sumitomo Pharmaceuticals Company, Limited |
Nuevos derivados de purina.
|
US5866702A
(en)
|
1996-08-02 |
1999-02-02 |
Cv Therapeutics, Incorporation |
Purine inhibitors of cyclin dependent kinase 2
|
US6630496B1
(en)
|
1996-08-26 |
2003-10-07 |
Genetics Institute Llc |
Inhibitors of phospholipase enzymes
|
JPH10231297A
(ja)
|
1997-02-20 |
1998-09-02 |
Japan Energy Corp |
新規なアデニン−1−n−オキシド誘導体およびその医薬用途
|
CN1130363C
(zh)
|
1997-11-12 |
2003-12-10 |
三菱化学株式会社 |
嘌呤衍生物以及含有其作为有效成分的药物
|
TW572758B
(en)
|
1997-12-22 |
2004-01-21 |
Sumitomo Pharma |
Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives
|
ID26123A
(id)
|
1998-02-25 |
2000-11-23 |
Genetics Inst |
Penghambat-penghambat phospholipase a2
|
US6828344B1
(en)
|
1998-02-25 |
2004-12-07 |
Genetics Institute, Llc |
Inhibitors of phospholipase enzymes
|
JP2002504539A
(ja)
|
1998-02-25 |
2002-02-12 |
ジェネティックス・インスチチュート・インコーポレーテッド |
ホスホリパーゼ酵素の阻害剤
|
US6479487B1
(en)
|
1998-02-26 |
2002-11-12 |
Aventis Pharmaceuticals Inc. |
6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines
|
HUP0102563A3
(en)
|
1998-05-04 |
2003-04-28 |
Zentaris Gmbh |
Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation
|
JP4549534B2
(ja)
|
1998-05-26 |
2010-09-22 |
中外製薬株式会社 |
複素環を有するインドール誘導体及びモノ又はジアザインドール誘導体
|
JP3997651B2
(ja)
|
1998-06-24 |
2007-10-24 |
コニカミノルタホールディングス株式会社 |
新規色素及び画像記録材料及び感熱転写材料及びインクジェット記録液
|
ES2342240T3
(es)
|
1998-08-11 |
2010-07-02 |
Novartis Ag |
Derivados de isoquinolina con actividad que inhibe la angiogenia.
|
ATE256677T1
(de)
|
1998-08-25 |
2004-01-15 |
Uab Research Foundation |
Inhibitoren der bakteriellen nad synthetase
|
US6133031A
(en)
|
1999-08-19 |
2000-10-17 |
Isis Pharmaceuticals Inc. |
Antisense inhibition of focal adhesion kinase expression
|
ES2246829T3
(es)
|
1999-02-01 |
2006-03-01 |
Cv Therapeutics Inc |
Inhibidores purinicos de cinasa 2 y de ikb-alfa dependientes de ciclina.
|
GB9905075D0
(en)
|
1999-03-06 |
1999-04-28 |
Zeneca Ltd |
Chemical compounds
|
JP2000281654A
(ja)
|
1999-03-26 |
2000-10-10 |
Tanabe Seiyaku Co Ltd |
イソキノリン誘導体
|
DE19932571A1
(de)
|
1999-07-13 |
2001-01-18 |
Clariant Gmbh |
Verfahren zur Herstellung von Biarylen unter Palladophosphacyclobutan-Katalyse
|
JP2001151771A
(ja)
|
1999-09-10 |
2001-06-05 |
Kyowa Hakko Kogyo Co Ltd |
含窒素芳香族複素環誘導体
|
GB0004890D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
US6436965B1
(en)
|
2000-03-02 |
2002-08-20 |
Merck Frosst Canada & Co. |
PDE IV inhibiting amides, compositions and methods of treatment
|
EP1138328A1
(en)
|
2000-03-29 |
2001-10-04 |
Eli Lilly And Company Limited |
Naphthalene derivatives as CNS drugs
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
PT1294358E
(pt)
|
2000-06-28 |
2004-12-31 |
Smithkline Beecham Plc |
Processo de moagem por via humida
|
CN1331340A
(zh)
|
2000-06-30 |
2002-01-16 |
上海博德基因开发有限公司 |
一种新的多肽——人拓扑异构酶12.1和编码这种多肽的多核苷酸
|
KR100748294B1
(ko)
|
2000-07-05 |
2007-08-09 |
아스텔라스세이야쿠 가부시키가이샤 |
프로판-1,3-디온 유도체
|
FR2814073B1
(fr)
|
2000-09-21 |
2005-06-24 |
Yang Ji Chemical Company Ltd |
Composition pharmaceutique antifongique et/ou antiparasitaire et nouveaux derives de l'indole a titre de principes actifs d'une telle composition
|
DOP2002000334A
(es)
|
2001-02-14 |
2002-08-30 |
Warner Lambert Co |
Pirimidinas biciclicas como inhibidores de metaloproteinasas de matriz
|
SE0100568D0
(sv)
|
2001-02-20 |
2001-02-20 |
Astrazeneca Ab |
Compounds
|
MXPA03007765A
(es)
|
2001-03-01 |
2003-12-08 |
Shionogi & Co |
Compuestos heteroarilo que contienen nitrogeno, que tienen actividad inhibitoria contra virus de inmunodeficiencia humana integrasa.
|
UA76977C2
(en)
|
2001-03-02 |
2006-10-16 |
Icos Corp |
Aryl- and heteroaryl substituted chk1 inhibitors and their use as radiosensitizers and chemosensitizers
|
US20050107400A1
(en)
|
2001-03-30 |
2005-05-19 |
Boyd Leslie F. |
Use of pyrazolopyridines as therapeutic compounds
|
EP1372643A1
(en)
|
2001-03-30 |
2004-01-02 |
Smithkline Beecham Corporation |
Pyrazolopyridines, process for their preparation and use as therapeutic compounds
|
JP2004527560A
(ja)
|
2001-04-27 |
2004-09-09 |
スミスクライン ビーチャム コーポレーション |
ピラゾロ[1,5−α]ピリジン誘導体
|
CZ294535B6
(cs)
|
2001-08-02 |
2005-01-12 |
Ústav Experimentální Botaniky Avčr |
Heterocyklické sloučeniny na bázi N6-substituovaného adeninu, způsoby jejich přípravy, jejich použití pro přípravu léčiv, kosmetických přípravků a růstových regulátorů, farmaceutické přípravky, kosmetické přípravky a růstové regulátory tyto sloučeniny obsahující
|
GB0121033D0
(en)
|
2001-08-30 |
2001-10-24 |
Novartis Ag |
Organic compounds
|
US8124625B2
(en)
|
2001-09-14 |
2012-02-28 |
Shionogi & Co., Ltd. |
Method of enhancing the expression of apolipoprotein AI using olefin derivatives
|
CN100391958C
(zh)
|
2001-09-19 |
2008-06-04 |
安万特医药股份有限公司 |
化合物
|
JP2005504807A
(ja)
|
2001-09-26 |
2005-02-17 |
バイエル・フアーマシユーチカルズ・コーポレーシヨン |
抗糖尿病薬としての1,8−ナフチリジン誘導体
|
AU2002341920A1
(en)
|
2001-10-02 |
2003-04-14 |
Smithkline Beecham Corporation |
Chemical compounds
|
KR20090087139A
(ko)
|
2001-10-30 |
2009-08-14 |
노파르티스 아게 |
Flt3 수용체 티로신 키나아제 활성의 억제제로서의 스타우로스포린 유도체
|
CA2465090C
(en)
|
2001-11-09 |
2010-02-02 |
Enzon, Inc. |
Polymeric thiol-linked prodrugs employing benzyl elimination systems
|
EP1314733A1
(en)
|
2001-11-22 |
2003-05-28 |
Aventis Pharma Deutschland GmbH |
Indole-2-carboxamides as factor Xa inhibitors
|
ATE424388T1
(de)
|
2001-12-06 |
2009-03-15 |
Merck & Co Inc |
Mitotische kinesinhemmer
|
AU2002357053B2
(en)
|
2001-12-06 |
2008-05-15 |
Merck Sharp & Dohme Corp. |
Mitotic kinesin inhibitors
|
TW200301135A
(en)
|
2001-12-27 |
2003-07-01 |
Otsuka Maryland Res Inst Inc |
Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor
|
AU2003211931A1
(en)
|
2002-02-13 |
2003-09-04 |
Takeda Chemical Industries, Ltd. |
Jnk inhibitor
|
US20050049267A1
(en)
|
2002-03-01 |
2005-03-03 |
Pintex Pharmaceuticals, Inc. |
Pin1-modulating compounds and methods of use thereof
|
US6933294B2
(en)
|
2002-04-03 |
2005-08-23 |
Bristol-Myers Squibb Company |
Thiophene-based tricyclic compounds and pharmaceutical compositions comprising same
|
KR20050006221A
(ko)
|
2002-05-06 |
2005-01-15 |
제네랩스 테크놀로지스, 인코포레이티드 |
C형 간염 바이러스 감염 치료용의 뉴클레오시드 유도체
|
PE20040522A1
(es)
|
2002-05-29 |
2004-09-28 |
Novartis Ag |
Derivados de diarilurea dependientes de la cinasa de proteina
|
GB0215676D0
(en)
|
2002-07-05 |
2002-08-14 |
Novartis Ag |
Organic compounds
|
US7358249B2
(en)
|
2002-08-13 |
2008-04-15 |
Shionogi & Co., Ltd. |
Heterocyclic compounds having inhibitory activity against HIV integrase
|
JP4190232B2
(ja)
|
2002-08-26 |
2008-12-03 |
富士通株式会社 |
機械研磨を行う方法
|
AU2003271064B2
(en)
|
2002-09-27 |
2010-06-17 |
Dainippon Sumitomo Pharma Co., Ltd. |
Novel adenine compound and use thereof
|
CL2003002353A1
(es)
|
2002-11-15 |
2005-02-04 |
Vertex Pharma |
Compuestos derivados de diaminotriazoles, inhibidores d ela proteina quinasa; composicion farmaceutica; procedimiento de preparacion; y su uso del compuesto en el tratamiento de enfermedades de desordenes alergicos, proliferacion, autoinmunes, condic
|
CA2507100C
(en)
|
2002-11-21 |
2012-10-09 |
Chiron Corporation |
2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
|
US7494987B2
(en)
|
2002-11-25 |
2009-02-24 |
Mochida Pharmaceutical Co., Ltd. |
Agent for treating respiratory diseases containing 4-hydroxypiperidine derivative as active ingredient
|
UA80767C2
(en)
|
2002-12-20 |
2007-10-25 |
Pfizer Prod Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
JP4500689B2
(ja)
|
2002-12-26 |
2010-07-14 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
選択的エストロゲン受容体モジュレーター
|
CZ294538B6
(cs)
|
2002-12-30 |
2005-01-12 |
Ústav Experimentální Botaniky Akademie Vědčeské Re |
Substituční deriváty N6-benzyladenosinu, způsob jejich přípravy, jejich použití pro přípravu léčiv, kosmetických přípravků a růstových regulátorů, farmaceutické přípravky, kosmetické přípravky a růstové regulátory tyto sloučeniny obsahující
|
RU2233842C1
(ru)
|
2003-01-13 |
2004-08-10 |
Петров Владимир Иванович |
Производные пурина, обладающие противовирусной активностью
|
PE20050068A1
(es)
|
2003-02-06 |
2005-03-11 |
Novartis Ag |
2-cianopirrolopirimidinas como inhibidores de la catepsina s
|
GB0304640D0
(en)
|
2003-02-28 |
2003-04-02 |
Novartis Ag |
Organic compounds
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
SE0300908D0
(sv)
|
2003-03-31 |
2003-03-31 |
Astrazeneca Ab |
Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
|
US7129264B2
(en)
|
2003-04-16 |
2006-10-31 |
Bristol-Myers Squibb Company |
Biarylmethyl indolines and indoles as antithromboembolic agents
|
JP2007501272A
(ja)
|
2003-05-05 |
2007-01-25 |
ニューロジェン・コーポレーション |
置換イミダゾロピラジンおよびトリアゾロピラジン誘導体類:gabaaレセプタリガンド類
|
ES2339862T3
(es)
|
2003-06-20 |
2010-05-26 |
Novartis Vaccines And Diagnostics, Inc. |
Compuestos de piridino 1,2-a-pirimidin-4-ona como agentes anticancerosos.
|
WO2005000309A2
(en)
|
2003-06-27 |
2005-01-06 |
Ionix Pharmaceuticals Limited |
Chemical compounds
|
JP4570015B2
(ja)
|
2003-07-14 |
2010-10-27 |
クミアイ化学工業株式会社 |
2−イソオキサゾリン誘導体及びそれを有効成分として含有する除草剤
|
MXPA06001758A
(es)
|
2003-08-15 |
2006-08-11 |
Irm Llc |
Anilino purinas sustituidas en la posicion 6 utiles como inhibidores de rtk.
|
CN101906106A
(zh)
|
2003-09-18 |
2010-12-08 |
康福玛医药公司 |
作为hsp90-抑制剂的新的杂环化合物
|
WO2005046578A2
(en)
|
2003-09-23 |
2005-05-26 |
Merck & Co., Inc. |
Isoquinolinone potassium channel inhibitors
|
PE20050952A1
(es)
|
2003-09-24 |
2005-12-19 |
Novartis Ag |
Derivados de isoquinolina como inhibidores de b-raf
|
CA2553724A1
(en)
|
2004-02-03 |
2005-08-18 |
Abbott Laboratories |
Aminobenzoxazoles as therapeutic agents
|
EP1717238A4
(en)
|
2004-02-16 |
2008-03-05 |
Daiichi Seiyaku Co |
FUNGICIDES HETEROCYCLIC COMPOUNDS
|
CN1560035A
(zh)
|
2004-03-12 |
2005-01-05 |
沈阳药科大学 |
5-羟基吲哚-3-羧酸脂类衍生物
|
WO2005091857A2
(en)
|
2004-03-12 |
2005-10-06 |
Bayer Pharmaceuticals Corporation |
1,6-naphthyridine and 1,8-naphthyridine derivatives and their use to treat diabetes and related disorders
|
JPWO2005092892A1
(ja)
|
2004-03-26 |
2008-02-14 |
大日本住友製薬株式会社 |
8−オキソアデニン化合物
|
JP2007531729A
(ja)
|
2004-04-02 |
2007-11-08 |
アデノシン、セラピューティックス、リミテッド、ライアビリティ、カンパニー |
A2aアデノシンレセプターの選択的アンタゴニスト
|
CA2566609C
(en)
|
2004-05-13 |
2012-06-26 |
Icos Corporation |
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
|
EP1753428A4
(en)
|
2004-05-14 |
2010-09-15 |
Abbott Lab |
INHIBITORS OF KINASES AS THERAPEUTIC AGENTS
|
BRPI0513513A
(pt)
|
2004-07-22 |
2008-05-06 |
Astrazeneca Ab |
composto ou um sal farmaceuticamente aceitável do mesmo, processo para preparar o mesmo, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, métodos para produzir um efeito inibitório de eg5 e um efeito anticáncer em um animal de sangue quente, e para tratar carcinomas em um animal de sangue quente
|
MX2007001953A
(es)
|
2004-08-18 |
2007-05-09 |
Astrazeneca Ab |
Enantiomeros de pirimidonas fusionadas seleccionadas y usos en el tratamiento y prevencion del cancer.
|
DE102004044221A1
(de)
|
2004-09-14 |
2006-03-16 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 3-Methyl-7-butinyl-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
RU2007118523A
(ru)
|
2004-10-19 |
2008-11-27 |
Новартис Вэксинс Энд Диагностикс Инк. (Us) |
Производные индола и бензимидазола
|
US20080004269A1
(en)
|
2004-11-04 |
2008-01-03 |
Yuelian Xu |
Pyrazolylmethy Heteroaryl Derivatives
|
US9512125B2
(en)
|
2004-11-19 |
2016-12-06 |
The Regents Of The University Of California |
Substituted pyrazolo[3.4-D] pyrimidines as anti-inflammatory agents
|
JP2008520612A
(ja)
|
2004-11-24 |
2008-06-19 |
ノバルティス アクチエンゲゼルシャフト |
JAK阻害剤およびBcr−Abl、Flt−3、FAKまたはRAFキナーゼ阻害剤のうち少なくとも1個の組合せ
|
EP1885356A2
(en)
|
2005-02-17 |
2008-02-13 |
Icos Corporation |
Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation
|
ATE474829T1
(de)
|
2005-06-27 |
2010-08-15 |
Amgen Inc |
Entzündungshemmende arylnitrilverbindungen
|
FR2889192A1
(fr)
|
2005-07-27 |
2007-02-02 |
Cytomics Systems Sa |
Composes antifongiques, compositions contenant ces composes et leurs utilisations
|
CA2619881A1
(en)
|
2005-08-16 |
2007-02-22 |
Genzyme Corporation |
Chemokine receptor binding compounds
|
US7642270B2
(en)
|
2005-09-14 |
2010-01-05 |
Janssen Pharmaceutica N.V. |
5-oxo-5,8-dihydro-pyrido-pyrimidine as inhibitors of c-fms kinase
|
US20090118263A1
(en)
|
2005-09-22 |
2009-05-07 |
Dainippon Sumitomo Pharma Co., Ltd. |
Novel Adenine Compound
|
GB0520657D0
(en)
*
|
2005-10-11 |
2005-11-16 |
Ludwig Inst Cancer Res |
Pharmaceutical compounds
|
NZ592990A
(en)
|
2005-11-01 |
2013-01-25 |
Targegen Inc |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
EP1783114A1
(en)
|
2005-11-03 |
2007-05-09 |
Novartis AG |
N-(hetero)aryl indole derivatives as pesticides
|
ES2353549T3
(es)
|
2005-11-10 |
2011-03-03 |
Chemocentryx, Inc. |
Quinolonas sustituidas y métodos de uso.
|
LT2474545T
(lt)
|
2005-12-13 |
2017-02-27 |
Incyte Holdings Corporation |
Heteroarilu pakeisti pirolo[2,3-b]piridinai ir pirolo[2,3-b]pirimidinai kaip janus kinazės inhibitoriai
|
US7989461B2
(en)
|
2005-12-23 |
2011-08-02 |
Amgen Inc. |
Substituted quinazolinamine compounds for the treatment of cancer
|
WO2007087548A2
(en)
|
2006-01-25 |
2007-08-02 |
Smithkline Beecham Corporation |
Chemical compounds
|
PE20071025A1
(es)
|
2006-01-31 |
2007-10-17 |
Mitsubishi Tanabe Pharma Corp |
Compuesto amina trisustituido
|
PE20070978A1
(es)
|
2006-02-14 |
2007-11-15 |
Novartis Ag |
COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE FOSFATIDILINOSITOL 3-QUINASAS (PI3Ks)
|
JPWO2007102392A1
(ja)
|
2006-03-03 |
2009-07-23 |
塩野義製薬株式会社 |
Mmp−13選択的阻害剤
|
EP2007373A4
(en)
|
2006-03-29 |
2012-12-19 |
Foldrx Pharmaceuticals Inc |
INHIBITION OF ALPHA SYNUCLEINE TOXICITY
|
US20080032960A1
(en)
*
|
2006-04-04 |
2008-02-07 |
Regents Of The University Of California |
PI3 kinase antagonists
|
DE102006029074A1
(de)
*
|
2006-06-22 |
2007-12-27 |
Friedrich-Schiller-Universität Jena |
4-Amino-3-arylamino-6-arylpyrazolo[3,4-d]pyrimidin-Derivate, Verfahren zu ihrer Herstellung und deren Verwendung als antivirale Wirkstoffe
|
EP2037905B1
(en)
|
2006-06-23 |
2013-05-01 |
Radius Health, Inc. |
Treatment of vasomotor symptoms with selective estrogen receptor modulators
|
EP2044086A2
(en)
|
2006-06-30 |
2009-04-08 |
Janssen Pharmaceutica N.V. |
Thiazolopyrimidine modulators of trpv1
|
US20080009508A1
(en)
|
2006-07-10 |
2008-01-10 |
Lucie Szucova |
6,9-Disubstituted Purine Derivatives And Their Use For Treating Skin
|
WO2008006540A1
(en)
|
2006-07-12 |
2008-01-17 |
Syngenta Participations Ag |
Triazolopyridine derivatives as herbicides
|
EP2050749B1
(en)
|
2006-08-08 |
2017-11-22 |
Chugai Seiyaku Kabushiki Kaisha |
Pyrimidine derivative as pi3k inhibitor and use thereof
|
WO2008025821A1
(en)
|
2006-08-30 |
2008-03-06 |
Cellzome Limited |
Triazole derivatives as kinase inhibitors
|
WO2008032033A1
(en)
|
2006-09-14 |
2008-03-20 |
Astrazeneca Ab |
4-benzimidazolyl-2-morpholino-6-piperazinylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders
|
EP1972631A1
(en)
|
2007-03-23 |
2008-09-24 |
Novartis AG |
Imidazopyridazines as PI3K lipid kinase inhibitors
|
WO2008055013A2
(en)
|
2006-10-31 |
2008-05-08 |
Janssen Pharmaceutica N.V. |
5-oxo-5,8 - dihydro - pyrido - pyrimidines as inhibitors of c-fms kinase
|
CN101605797A
(zh)
|
2006-11-13 |
2009-12-16 |
伊莱利利公司 |
治疗炎症疾病和癌症的噻吩并嘧啶酮
|
PL2099447T3
(pl)
|
2006-11-22 |
2013-06-28 |
Incyte Holdings Corp |
Imidazotriazyny i imidazopirmidyny jako inhibitory kinaz
|
CN101631786A
(zh)
|
2006-12-20 |
2010-01-20 |
先灵公司 |
新颖的jnk抑制剂
|
WO2008080844A1
(en)
|
2006-12-29 |
2008-07-10 |
F. Hoffmann-La Roche Ag |
Azaspiro derivatives
|
EP2079737A1
(en)
|
2007-02-05 |
2009-07-22 |
Xenon Pharmaceuticals Inc. |
Pyridopyrimidinone compounds useful in treating sodium channel-mediated diseases or conditions
|
MX2009008439A
(es)
|
2007-02-12 |
2009-08-13 |
Intermune Inc |
Nuevos inhibidores de la replicacion del virus de hepatitis c.
|
TW200902018A
(en)
|
2007-03-20 |
2009-01-16 |
Dainippon Sumitomo Pharma Co |
Novel adenine compound
|
US20080233127A1
(en)
|
2007-03-21 |
2008-09-25 |
Wyeth |
Imidazolopyrimidine analogs and their use as pi3 kinase and mtor inhibitors
|
ES2563458T3
(es)
|
2007-03-23 |
2016-03-15 |
Amgen Inc. |
Compuestos heterocíclicos y sus usos
|
WO2008118454A2
(en)
|
2007-03-23 |
2008-10-02 |
Amgen Inc. |
Derivatives of quinoline or benzopyrazine and their uses for the treatment of (inter alia) inflammatory diseases, autoimmune diseases or various kinds of cancer
|
US8039505B2
(en)
|
2007-04-11 |
2011-10-18 |
University Of Utah Research Foundation |
Compounds for modulating T-cells
|
US8633186B2
(en)
|
2007-06-08 |
2014-01-21 |
Senomyx Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
US9603848B2
(en)
|
2007-06-08 |
2017-03-28 |
Senomyx, Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
EP2167058B1
(en)
|
2007-06-18 |
2015-08-12 |
University Of Louisville Research Foundation, Inc. |
Family of pfkfb3 inhibitors with anti-neoplastic activities
|
US7968544B2
(en)
|
2007-06-29 |
2011-06-28 |
Gilead Sciences, Inc. |
Modulators of toll-like receptor 7
|
CA2696113A1
(en)
|
2007-08-10 |
2009-04-02 |
Burnham Institute For Medical Research |
Tissue-nonspecific alkaline phosphatase (tnap) activators and uses thereof
|
JP2009076865A
(ja)
|
2007-08-29 |
2009-04-09 |
Fujifilm Corp |
有機電界発光素子
|
WO2009026701A1
(en)
|
2007-08-29 |
2009-03-05 |
Methylgene Inc. |
Sirtuin inhibitors
|
WO2009034386A1
(en)
|
2007-09-13 |
2009-03-19 |
Astrazeneca Ab |
Derivatives of adenine and 8-aza-adenine and uses thereof-796
|
JP2009080233A
(ja)
|
2007-09-26 |
2009-04-16 |
Kyocera Mita Corp |
電子写真感光体
|
CZ300774B6
(cs)
|
2007-10-05 |
2009-08-05 |
Univerzita Palackého |
Substituované 6-(alkylbenzylamino)purinové deriváty pro použití jako antagonisté cytokininových receptoru a prípravky obsahující tyto slouceniny
|
US20100331297A1
(en)
|
2007-11-07 |
2010-12-30 |
Foldrx Pharmaceuticals, Inc. |
Modulation of protein trafficking
|
WO2009063235A1
(en)
|
2007-11-13 |
2009-05-22 |
Astrazeneca Ab |
Derivatives of 1,9-dihydro-6h-purin-6-one and uses thereof-018
|
JP2009120686A
(ja)
|
2007-11-14 |
2009-06-04 |
Toyo Ink Mfg Co Ltd |
光重合開始剤、重合性組成物、および重合物の製造方法。
|
CA2710194C
(en)
|
2007-12-19 |
2014-04-22 |
Amgen Inc. |
Inhibitors of p13 kinase
|
US8399483B2
(en)
|
2007-12-21 |
2013-03-19 |
Ucb Pharma S.A. |
Quinoxaline and quinoline derivatives as kinase inhibitors
|
AU2008345225A1
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
JP2011507900A
(ja)
|
2007-12-21 |
2011-03-10 |
ワイス・エルエルシー |
イミダゾ[1,2−a]ピリジン化合物
|
US7960397B2
(en)
|
2007-12-28 |
2011-06-14 |
Institute Of Experimental Botany, Academy Of Sciences Of The Czech Republic |
6,9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions
|
BRPI0722222A2
(pt)
|
2007-12-28 |
2015-06-16 |
Topharman Shangai Co Ltd |
N-{1-[3-(2-etóxi-5-(4-etilpiperazinil)sulfonilfenil)-4,5-di hidro-5-oxo-1,2,4-triazina-6-il]etil}butiramida, seu método de preparo e seu uso
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
CA2711777A1
(en)
|
2008-01-11 |
2009-08-13 |
Natco Pharma Limited |
Novel pyrazolo [3,4-d] pyrimidine derivatives as anti-cancer drugs
|
US9089572B2
(en)
|
2008-01-17 |
2015-07-28 |
California Institute Of Technology |
Inhibitors of p97
|
EP2252616B1
(en)
|
2008-01-30 |
2014-07-23 |
Genentech, Inc. |
Pyrazolopyrimidine pi3k inhibitor compounds and methods of use
|
JPWO2009128520A1
(ja)
|
2008-04-18 |
2011-08-04 |
塩野義製薬株式会社 |
Pi3k阻害活性を有する複素環化合物
|
US8119647B2
(en)
|
2008-04-23 |
2012-02-21 |
Glenmark Pharmaceuticals S.A. |
Fused pyrimidineone compounds as TRPV3 modulators
|
WO2009140215A2
(en)
|
2008-05-11 |
2009-11-19 |
Geraghty, Erin |
Method for treating drug-resistant bacterial and other infections with clioquinol, phanquinone, and related compounds
|
EP2300005A4
(en)
|
2008-05-28 |
2011-07-13 |
Us Of America As Represented By The Secretary Of The Army On Behalf Of U S Army Medical Res And Mate |
Small-molecule inhibitors of botulinum neurotoxins
|
EP2303859A4
(en)
|
2008-06-20 |
2012-08-22 |
Metabolex Inc |
ARYL GPR119 AGONISTS AND USES THEREOF
|
US8026271B2
(en)
|
2008-07-11 |
2011-09-27 |
National Health Research Institutes |
Formulations of indol-3-yl-2-oxoacetamide compounds
|
WO2010018458A2
(en)
|
2008-08-12 |
2010-02-18 |
Crystalgenomics, Inc. |
Phenol derivatives and methods of use thereof
|
WO2010036380A1
(en)
*
|
2008-09-26 |
2010-04-01 |
Intellikine, Inc. |
Heterocyclic kinase inhibitors
|
NZ611764A
(en)
|
2008-11-13 |
2015-01-30 |
Gilead Calistoga Llc |
Therapies for hematologic malignancies
|
US20110245209A1
(en)
|
2008-12-16 |
2011-10-06 |
Schering Corporation |
Pyridopyrimidine derivatives and methods of use thereof
|
BR122013027950A2
(pt)
|
2008-12-24 |
2019-12-10 |
BIAL PORTELA & Cª S A |
compostos farmacêuticos
|
US8563579B2
(en)
|
2009-01-15 |
2013-10-22 |
Anvyl Llc |
α-7 nicotinic acetylcholine receptor allosteric modulators, their derivatives and uses thereof
|
WO2010092340A1
(en)
|
2009-02-13 |
2010-08-19 |
Ucb Pharma S.A. |
Fused pyridine and pyrazine derivatives as kinase inhibitors
|
CA2756808A1
(en)
|
2009-03-31 |
2010-10-07 |
Arqule, Inc. |
Substituted indolo-piperidine compounds
|
WO2010118367A2
(en)
|
2009-04-10 |
2010-10-14 |
Progenics Pharmaceuticals, Inc. |
Antiviral pyrimidines
|
SG175259A1
(en)
|
2009-04-20 |
2011-11-28 |
Gilead Calistoga Llc |
Methods of treatment for solid tumors
|
WO2010127208A1
(en)
|
2009-04-30 |
2010-11-04 |
Forest Laboratories Holdings Limited |
Inhibitors of acetyl-coa carboxylase
|
EP2427195B1
(en)
|
2009-05-07 |
2019-05-01 |
Intellikine, LLC |
Heterocyclic compounds and uses thereof
|
JP5775070B2
(ja)
|
2009-05-22 |
2015-09-09 |
インサイト・コーポレイションIncyte Corporation |
ヤヌスキナーゼ阻害剤としてのピラゾール−4−イル−ピロロ[2,3−d]ピリミジンおよびピロール−3−イル−ピロロ[2,3−d]ピリミジンのN−(ヘテロ)アリール−ピロリジン誘導体
|
US20100331306A1
(en)
|
2009-06-25 |
2010-12-30 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
AU2010266064A1
(en)
|
2009-06-25 |
2012-01-19 |
Amgen Inc. |
4H - pyrido [1, 2 - a] pyrimidin - 4 - one derivatives as PI3 K inhibitors
|
AR077252A1
(es)
|
2009-06-29 |
2011-08-10 |
Xenon Pharmaceuticals Inc |
Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
|
SG177434A1
(en)
|
2009-06-29 |
2012-02-28 |
Agios Pharmaceuticals Inc |
Therapeutic compounds and compositions
|
PL2448938T3
(pl)
|
2009-06-29 |
2014-11-28 |
Incyte Holdings Corp |
Pirymidynony jako inhibitory PI3K
|
FR2947269B1
(fr)
|
2009-06-29 |
2013-01-18 |
Sanofi Aventis |
Nouveaux composes anticancereux
|
WO2011011550A1
(en)
|
2009-07-21 |
2011-01-27 |
Calistoga Pharmaceuticals Inc. |
Treatment of liver disorders with pi3k inhibitors
|
ES2432315T3
(es)
|
2009-08-28 |
2013-12-02 |
Takeda Pharmaceutical Company Limited |
Compuestos de hexahidrooxazinopterina para su uso como inhibidores de mTOR
|
US9249145B2
(en)
|
2009-09-01 |
2016-02-02 |
Incyte Holdings Corporation |
Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
AU2010309882B2
(en)
|
2009-10-20 |
2016-01-28 |
Cellzome Limited |
Heterocyclyl pyrazolopyrimidine analogues as JAK inhibitors
|
NO2491035T3
(pl)
|
2009-10-22 |
2018-01-27 |
|
|
CN105801550B
(zh)
*
|
2009-11-05 |
2019-06-14 |
理森制药股份公司 |
新型苯并吡喃激酶调节剂
|
EP2947082A1
(en)
|
2009-11-10 |
2015-11-25 |
Pfizer Inc |
N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS
|
EP2499126B1
(en)
|
2009-11-12 |
2015-01-07 |
UCB Pharma, S.A. |
Fused bicyclic pyridine and pyrazine derivatives as kinase inhibitors
|
WO2011058111A1
(en)
|
2009-11-12 |
2011-05-19 |
Ucb Pharma S.A. |
Aminopurine derivatives as kinase inhibitors
|
WO2011069294A1
(zh)
|
2009-12-10 |
2011-06-16 |
中国医学科学院药物研究所 |
N6-取代腺苷衍生物和n6-取代腺嘌呤衍生物及其用途
|
WO2011075643A1
(en)
|
2009-12-18 |
2011-06-23 |
Incyte Corporation |
Substituted heteroaryl fused derivatives as pi3k inhibitors
|
WO2011075628A1
(en)
|
2009-12-18 |
2011-06-23 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
AR079529A1
(es)
|
2009-12-18 |
2012-02-01 |
Incyte Corp |
Derivados arilo y heteroarilo sustituidos y fundidos como inhibidores de la pi3k
|
CA2785353C
(en)
*
|
2009-12-23 |
2017-10-31 |
Palau Pharma, S.A. |
Aminoalkylpyrimidine derivatives as histamine h4 receptor antagonists
|
JP2011136925A
(ja)
|
2009-12-28 |
2011-07-14 |
Dainippon Sumitomo Pharma Co Ltd |
含窒素二環性化合物
|
CA2786250A1
(en)
|
2010-01-07 |
2011-07-14 |
Dow Agrosciences Llc |
Thiazolo[5,4-d] pyrimidines and their use as agrochemicals
|
UY33199A
(es)
|
2010-01-26 |
2011-08-31 |
Boehringer Ingelheim Int |
5-alquinil-pirimidinas.
|
AR081315A1
(es)
|
2010-03-10 |
2012-08-08 |
Incyte Corp |
Derivados heterociclicos de piperidin y pirimidin -4-il-azetidina, una forma cristalina de la sal del acido acetonitriladipico de un derivado pirimidinico, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades relacionadas con la inhibicion de jak-1, t
|
EP2549998A1
(en)
|
2010-03-22 |
2013-01-30 |
Glenmark Pharmaceuticals S.A. |
Pharmaceutical composition comprising a pyrimidineone derivative
|
UY33304A
(es)
|
2010-04-02 |
2011-10-31 |
Amgen Inc |
Compuestos heterocíclicos y sus usos
|
EP2558463A1
(en)
|
2010-04-14 |
2013-02-20 |
Incyte Corporation |
Fused derivatives as i3 inhibitors
|
ES2593256T3
(es)
|
2010-05-21 |
2016-12-07 |
Infinity Pharmaceuticals, Inc. |
Compuestos químicos, composiciones y métodos para las modulaciones de cinasas
|
US20110306622A1
(en)
|
2010-06-11 |
2011-12-15 |
Calitoga Pharmaceuticals, Inc. |
Methods of treating hematological disorders with quinazolinone compounds in selected subjects
|
US9062055B2
(en)
|
2010-06-21 |
2015-06-23 |
Incyte Corporation |
Fused pyrrole derivatives as PI3K inhibitors
|
MX2012014996A
(es)
|
2010-07-01 |
2013-03-21 |
Amgen Inc |
Compuestos heterociclicos y su uso como inhibidores de la actividad pi3k.
|
JP2013530238A
(ja)
|
2010-07-01 |
2013-07-25 |
アムジエン・インコーポレーテツド |
Pi3k活性の阻害剤としての複素環化合物及びその使用
|
MX2012015134A
(es)
|
2010-07-02 |
2013-05-06 |
Amgen Inc |
Compuestos heterociclicos y su uso como inhibidores de actividad de pi3k.
|
US20130324561A1
(en)
|
2010-09-24 |
2013-12-05 |
Gilead Calistroga Llc. |
Atropisomers of p13k-inhibiting compounds
|
WO2012061696A1
(en)
|
2010-11-04 |
2012-05-10 |
Amgen Inc. |
5 -cyano-4, 6 -diaminopyrimidine or 6 -aminopurine derivatives as pi3k- delta inhibitors
|
CA2817577A1
(en)
|
2010-11-10 |
2012-05-18 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
MX2013005567A
(es)
|
2010-11-17 |
2013-10-30 |
Amgen Inc |
Derivados de quinolina como inhibidores de pik3.
|
AR083933A1
(es)
|
2010-11-19 |
2013-04-10 |
Incyte Corp |
Derivados de pirrolopiridina y pirrolopirimidina sustituidos con ciclobutilo como inhibidores de jak
|
US9034884B2
(en)
|
2010-11-19 |
2015-05-19 |
Incyte Corporation |
Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as JAK inhibitors
|
DK2835131T3
(en)
|
2010-12-14 |
2017-12-04 |
Electrophoretics Ltd |
Casein kinase 1 delta inhibitors (CK1 delta)
|
TW201249844A
(en)
|
2010-12-20 |
2012-12-16 |
Incyte Corp |
N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors
|
AU2011349669A1
(en)
|
2010-12-23 |
2013-07-11 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
UA115767C2
(uk)
|
2011-01-10 |
2017-12-26 |
Інфініті Фармасьютікалз, Інк. |
Способи отримання ізохінолінонів і тверді форми ізохінолінонів
|
CA2825599C
(en)
|
2011-02-01 |
2021-07-13 |
The Board Of Trustees Of The University Of Illinois |
4-methyl-n-hydroxybenzamide compounds as histone deacetylase (hdac) inhibitors
|
WO2012125629A1
(en)
|
2011-03-14 |
2012-09-20 |
Incyte Corporation |
Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
|
US9126948B2
(en)
|
2011-03-25 |
2015-09-08 |
Incyte Holdings Corporation |
Pyrimidine-4,6-diamine derivatives as PI3K inhibitors
|
PE20140832A1
(es)
|
2011-06-20 |
2014-07-14 |
Incyte Corp |
Derivados de azetidinil fenil, piridil o pirazinil carboxamida como inhibidores de jak
|
US8969363B2
(en)
|
2011-07-19 |
2015-03-03 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為jak抑制劑之環己基氮雜環丁烷衍生物
|
KR102131612B1
(ko)
|
2011-09-02 |
2020-07-08 |
인사이트 홀딩스 코포레이션 |
Pi3k 억제제로서 헤테로시클릴아민
|
WO2013052699A2
(en)
|
2011-10-04 |
2013-04-11 |
Gilead Calistoga Llc |
Novel quinoxaline inhibitors of pi3k
|
AR090548A1
(es)
|
2012-04-02 |
2014-11-19 |
Incyte Corp |
Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
|
US9193733B2
(en)
|
2012-05-18 |
2015-11-24 |
Incyte Holdings Corporation |
Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
|
SG11201503141TA
(en)
|
2012-11-01 |
2015-06-29 |
Incyte Corp |
Tricyclic fused thiophene derivatives as jak inhibitors
|
TW202214254A
(zh)
|
2013-03-01 |
2022-04-16 |
美商英塞特控股公司 |
吡唑并嘧啶衍生物治療PI3Kδ相關病症之用途
|
SG10201809696UA
(en)
|
2013-03-15 |
2018-11-29 |
Janssen Pharmaceutica Nv |
Processes and intermediates for preparing a medicament
|
PE20200527A1
(es)
|
2013-05-17 |
2020-03-09 |
Incyte Corp |
Derivados del bipirazol como inhibidores jak
|
WO2015191677A1
(en)
|
2014-06-11 |
2015-12-17 |
Incyte Corporation |
Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors
|
TWI698436B
(zh)
|
2014-12-30 |
2020-07-11 |
美商佛瑪治療公司 |
作為泛素特異性蛋白酶7抑制劑之吡咯并及吡唑并嘧啶
|
MA41607B1
(fr)
|
2015-02-27 |
2021-01-29 |
Incyte Corp |
Sels d'un inhibiteur de pi3k et procédés de préparation de ces sels
|
WO2016183063A1
(en)
|
2015-05-11 |
2016-11-17 |
Incyte Corporation |
Crystalline forms of a pi3k inhibitor
|
US20160362424A1
(en)
|
2015-05-11 |
2016-12-15 |
Incyte Corporation |
Salts of (s)-7-(1-(9h-purin-6-ylamino)ethyl)-6-(3-fluorophenyl)-3-methyl-5h-thiazolo[3,2-a]pyrimidin-5-one
|
WO2016183060A1
(en)
|
2015-05-11 |
2016-11-17 |
Incyte Corporation |
Process for the synthesis of a phosphoinositide 3-kinase inhibitor
|
KR20210018328A
(ko)
|
2018-06-01 |
2021-02-17 |
인사이트 코포레이션 |
Pi3k 관련 장애의 치료를 위한 투여 요법
|